South America Manufacturing, Packaging & Detailing Market Research Reports - Data on Manufacturing, Packaging & Detailing in South America page 1

Printer Format

Region:	All Regions > South America
Category:	All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing

(94 reports matching your criteria)

Brazil Pharmaceuticals and Healthcare Report Q3 2013 6/12/2013 \| published by: Business Monitor International ... the attractions of the private healthcaresector are substantial to foreign investors due to the country's positive long-term economic outlook,growing middle-class population and its traditional commitment to improve healthcare. Headline Expenditure Projections Pharmaceuticals: BRL52.4bn (US$26.8bn) in ... \| read more...	$1,295.00
Argentina Pharmaceuticals and Healthcare Report Q3 2013 5/22/2013 \| published by: Business Monitor International ... size, relatively welldevelopedlocal manufacturing force and its strategic location mean Argentina remains an appealingprospect.. Headline Expenditure Projections: Pharmaceuticals: ARS39.4bn (US$8.7bn) in 2012 to ARS49.4bn (US$8.9bn) in 2013; +25.3% in localcurrency terms and 2.7% in US ... \| read more...	$1,295.00
Chemical & Pharmaceutical Plant Construction in Chile to 2017: Market Databook 5/13/2013 \| published by: Timetric ... chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ... \| read more...	$500.00
Chile Pharmaceuticals and Healthcare Report Q2 2013 5/1/2013 \| published by: Business Monitor International ... market. It will also help to bring local drugmakers upto international standards, and in the long term, improve their competitiveness in the domestic and regionalmarkets. Foreign drugmakers with products which have been held to tougher ... \| read more...	$1,175.00
Healthcare, Regulatory and Reimbursement Landscape - Argentina 4/22/2013 \| published by: GlobalData ... regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the ... \| read more...	$1,995.00
Peru Pharmaceuticals and Healthcare Report Q2 2013 4/17/2013 \| published by: Business Monitor International ... using Peru as a production hub to export to neighbouring countries. The strict regulatorystandards in Peru are also to the advantage of multinationals, which can leverage their industrialexpertise in production and reduce competition from local ... \| read more...	$1,175.00
Colombia Pharmaceuticals and Healthcare Report Q2 2013 4/10/2013 \| published by: Business Monitor International ... high per capita spending on medicines. Nevertheless, growingpharmaceutical demand will remain a substantial draw for foreign drugmakers. Headline Expenditure Projections Pharmaceuticals: COP7,548bn (US$4.20bn) in 2012 to COP8,071bn (US$4.45bn) in 2013;+6.9% in local currency terms and ... \| read more...	$1,175.00
Venezuela Pharmaceuticals and Healthcare Report Q2 2013 4/3/2013 \| published by: Business Monitor International ... to deviate from their currentcourse over the short-to-medium term. We therefore maintain our current forecast for the country'shealthcare expenditure and pharmaceutical market growth. However, we caution that political andeconomic uncertainties in the wake of Chávez's ... \| read more...	$1,175.00
Brazil Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... and pharmaceutical industry to reduce thefinancial burden of diseases, and the country's private healthcare sectors provide opportunities forforeign companies. However, the increasing drug rebate level has significantly undermined the profitsrecorded by generic drugmakers. The more ... \| read more...	$1,175.00
The 2013 Import and Export Market for Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... market in Latin America face a number of questions. Which countries are supplying medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins to Latin America? What is the dollar value of ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Antibiotics (Except Penicillins and Streptomycins) Excluding Those in Dosage Form or Retail Packings in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing antibiotics (except penicillins and streptomycins) excluding those in dosage form or retail packings to Latin America? What is ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... planners approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives to Latin America? ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Insulin Excluding Those in Dosage Form or Retail Packings in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... Latin America face a number of questions. Which countries are supplying medicaments containing insulin excluding those in dosage form or retail packings to Latin America? What is the dollar value of these imports? How much ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Insulin in Dosage Form or Retail Packings in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... face a number of questions. Which countries are supplying medicaments containing insulin in dosage form or retail packings to Latin America? What is the dollar value of these imports? How much do the imports of ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... the market in Latin America face a number of questions. Which countries are supplying medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings to Latin America? What is the dollar ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Penicillins, Streptomycins, or Their Derivatives Excluding Those in Dosage Form or Retail Packings in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing penicillins, streptomycins, or their derivatives excluding those in dosage form or retail packings to Latin America? What is ... \| read more...	$325.00
The 2013 Import and Export Market for Pharmaceutical Goods Excluding Medicaments in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... Which countries are supplying pharmaceutical goods excluding medicaments to Latin America? What is the dollar value of these imports? How much do the imports of pharmaceutical goods excluding medicaments vary from one country to another ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Antibiotics or Their Derivatives in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... of questions. Which countries are supplying medicaments containing antibiotics or their derivatives to Latin America? What is the dollar value of these imports? How much do the imports of medicaments containing antibiotics or their derivatives ... \| read more...	$325.00
The 2013 Import and Export Market for Penicillins and Derivatives with a Penicillanic Acid Structure and Salts Thereof in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... Latin America face a number of questions. Which countries are supplying penicillins and derivatives with a penicillanic acid structure and salts thereof to Latin America? What is the dollar value of these imports? How much ... \| read more...	$325.00
The 2013 Import and Export Market for Medicaments Containing Adrenal Cortical Hormones in Measured Doses or in Forms or Packings for Retail Sale in Latin America 1/1/2013 \| published by: Icon Group International, Inc. ... planners approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing adrenal cortical hormones in measured doses or in forms or packings for retail sale to Latin America? ... \| read more...	$325.00
Healthcare, Regulatory and Reimbursement Landscape - Venezuela 12/5/2012 \| published by: GlobalData ... on the healthcare, regulatory and reimbursement landscape of Venezuela. The report identifies the key trends in the healthcare market of Venezuela. The report also provides insights into the demographic, regulatory and reimbursement landscapes and the ... \| read more...	$1,995.00
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide 12/1/2012 \| published by: MarketLine ... value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. Scope of the Report Contains an executive summary and data on ... \| read more...	$995.00
Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets 11/30/2012 \| published by: Decision Resources ... by a growing prevalent population with greater access to medical care and by rheumatologists’ increasing use of more aggressive treatments. Increased government spending on healthcare and improved penetration of biological agents make this an attractive ... \| read more...	$10,000.00
Venezuela Pharmaceuticals and Healthcare Report Q4 2012 10/17/2012 \| published by: Business Monitor International ... revenue-generation opportunities fromVenezuela’s increasing reliance on imported products to meet local demand, as the election outcome willnot fix the production capacity issues in the domestic industry. Headline Expenditure Projections Pharmaceuticals: VEB33.26bn (US$5.46bn) in 2011 to ... \| read more...	$1,175.00
Chile Pharmaceuticals and Healthcare Report Q4 2012 10/3/2012 \| published by: Business Monitor International ... Indeed, it is our view thatemerging markets will be the main drivers of the pharmaceutical sector's expansion over the comingyears as growth in traditional markets such as the US, Western Europe and Japan remains lacklustre. ... \| read more...	$1,175.00

< prev 1 2 3 4 next >